Hope Elizabeth Uronis | Scholars@Duke

Hope Elizabeth Uronis
Associate Professor of Medicine

Current Appointments & Affiliations

Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2013
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2000

Contact Information

435 Seeley G. Mudd Building, Box 2823, Durham, NC 27710
Duke Box 2823, Durham, NC 27710
(919) 681-3480

Background
Education, Training, & Certifications
- Fellow in Hematology-Oncology, Medicine, Duke University 2005 - 2007
- Chief Medical Resident -Duke Hospital, Medicine, Duke University 2004 - 2005
- Fellow in Hematology-Oncology, Medicine, Duke University 2003 - 2004
- Medical Resident, Medicine, Duke University 2000 - 2003
- M.D., State University of New York at Buffalo 2000
Duke Appointment History
- Assistant Professor of Medici, Medicine, Medical Oncology, Medicine 2013
- Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2008 - 2012
- Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2007 - 2008
- Associate in the Department of Medicine, Medicine, Gastroenterology, Medicine 2004 - 2005
Recognition
In the News
- NOV 21, 2017
  
  Five Recognized With Inaugural Palliative Care Award
Expertise
Subject Headings
Research
Selected Grants
- MK 3475 - PN811 awarded by Merck Sharp & Dohme 2018 - 2023
- A Randomized multicenter double blind Phase III study of Nivolumab or placebo in subjects with resected esophageal junction cancer. awarded by Bristol-Myers Squibb Company 2016 - 2021
- A Multicenter randomized open label study in patients with esophageal cancer refractory or intorlerant to combination therapy with fluoropyrimidine awarded by Bristol-Myers Squibb Company 2016 - 2021
- A Phase 1b/2 open label dose escalation study of Margetuximab incombination with Pembrolizumab in patients with relapsed refrectory advanced HER2 + Gastroesophageal junction or gastric cancer. awarded by MacroGenics, Inc. 2016 - 2020
- Key LARGO: PII awarded by Merck Sharp & Dohme 2017 - 2020
- A Phase 2 study of ADXS11-001 i subjects with persistent/recurrent loco-regional or metastatic squamous cell carcinoma of the anorectal canal. awarded by Advaxis Inc 2015 - 2020
- LYC-55716-1001 awarded by Lycera Corporation 2017 - 2019
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Sohal, DPS, Kennedy, EB, Khorana, A, Copur, MS, Crane, CH, Garrido-Laguna, I, Krishnamurthi, S, Moravek, C, O'Reilly, EM, Philip, PA, Ramanathan, RK, Ruggiero, JT, Shah, MA, Urba, S, Uronis, HE, Lau, MW, and Laheru, D. "Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 36, no. 24 (August 2018): 2545-2556. Full Text
  - Vlahovic, G, Meadows, KL, Hatch, AJ, Jia, J, Nixon, AB, Uronis, HE, Morse, MA, Selim, MA, Crawford, J, Riedel, RF, Zafar, SY, Howard, LA, O'Neill, M, Meadows, JJ, Haley, ST, Arrowood, CC, Rushing, C, Pang, H, and Hurwitz, HI. "A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer." The Oncologist 23, no. 7 (July 2018): 782-790. Full Text
  - Porter, LS, Keefe, FJ, Baucom, DH, Olsen, M, Zafar, SY, and Uronis, H. "A randomized pilot trial of a videoconference couples communication intervention for advanced GI cancer." Psycho Oncology 26, no. 7 (July 2017): 1027-1035. Full Text
  - Spiegel, D, Palta, M, and Uronis, H. "Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma." The Surgical Clinics of North America 97, no. 2 (April 2017): 421-435. (Review) Full Text
  - Riedel, RF, Meadows, KL, Lee, PH, Morse, MA, Uronis, HE, Blobe, GC, George, DJ, Crawford, J, Niedzwiecki, D, Rushing, CN, Arrowood, CC, and Hurwitz, HI. "Phase I study of pazopanib plus TH-302 in advanced solid tumors." Cancer Chemotherapy and Pharmacology 79, no. 3 (March 2017): 611-619. Full Text
  - Susko, M, Lee, J, Salama, J, Thomas, S, Uronis, H, Hsu, D, Migaly, J, Willett, C, Czito, B, and Palta, M. "The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer." Annals of surgical oncology 23, no. 11 (October 2016): 3609-3615. Full Text
  - Sohal, DPS, Mangu, PB, Khorana, AA, Shah, MA, Philip, PA, O'Reilly, EM, Uronis, HE, Ramanathan, RK, Crane, CH, Engebretson, A, Ruggiero, JT, Copur, MS, Lau, M, Urba, S, and Laheru, D. "Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 23 (August 2016): 2784-2796. (Review) Full Text
  - Borad, MJ, Reddy, SG, Bahary, N, Uronis, HE, Sigal, D, Cohn, AL, Schelman, WR, Stephenson, J, Chiorean, EG, Rosen, PJ, Ulrich, B, Dragovich, T, Del Prete, SA, Rarick, M, Eng, C, Kroll, S, and Ryan, DP. "Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33, no. 13 (May 2015): 1475-1481. Full Text
  - Uronis, HE, Ekström, MP, Currow, DC, McCrory, DC, Samsa, GP, and Abernethy, AP. "Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis." Thorax 70, no. 5 (May 2015): 492-494. (Review) Full Text
  - Uronis, HE, Ekström, MP, Currow, DC, McCrory, DC, Samsa, GP, and Abernethy, AP. "Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: A systematic review and meta-analysis." Thorax 70, no. 5 (May 1, 2015): 492-494. Full Text
  - Liu, Y, Starr, MD, Brady, JC, Rushing, C, Bulusu, A, Pang, H, Honeycutt, W, Amara, A, Altomare, I, Uronis, HE, Hurwitz, HI, and Nixon, AB. "Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus." Molecular cancer therapeutics 14, no. 4 (April 2015): 1048-1056. Full Text
  - Uronis, HE, Jia, J, Bendell, JC, Howard, L, Ready, NA, Lee, PH, Starr, MD, Dellinger, A, Pang, H, Nixon, AB, and Hurwitz, HI. "A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors." Cancer chemotherapy and pharmacology 75, no. 2 (February 2015): 343-352. Full Text
  - Uronis, HE, Jia, J, Bendell, JC, Howard, L, Ready, NA, Lee, PH, Starr, MD, Dellinger, A, Pang, H, Nixon, AB, and Hurwitz, HI. "A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors." Cancer Chemotherapy and Pharmacology 75, no. 2 (January 1, 2015): 343-352. Full Text
  - Zhong, J, Palta, M, Willett, CG, McCall, SJ, McSherry, F, Tyler, DS, Uronis, HE, and Czito, BG. "Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience." Journal of gastrointestinal oncology 5, no. 6 (December 2014): 421-427. Full Text
  - Cleary, JM, Lima, CMSR, Hurwitz, HI, Montero, AJ, Franklin, C, Yang, J, Graham, A, Busman, T, Mabry, M, Holen, K, Shapiro, GI, and Uronis, H. "A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors." Investigational new drugs 32, no. 5 (October 2014): 937-945. Full Text
  - Rangwala, F, Bendell, JC, Kozloff, MF, Arrowood, CC, Dellinger, A, Meadows, J, Tourt-Uhlig, S, Murphy, J, Meadows, KL, Starr, A, Broderick, S, Brady, JC, Cushman, SM, Morse, MA, Uronis, HE, Hsu, SD, Zafar, SY, Wallace, J, Starodub, AN, Strickler, JH, Pang, H, Nixon, AB, and Hurwitz, HI. "Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors." Investigational New Drugs 32, no. 4 (August 2014): 700-709. Full Text
  - Dorth, JA, Pura, JA, Palta, M, Willett, CG, Uronis, HE, D'Amico, TA, and Czito, BG. "Patterns of recurrence after trimodality therapy for esophageal cancer." Cancer 120, no. 14 (July 2014): 2099-2105. Full Text
  - Strickler, JH, McCall, S, Nixon, AB, Brady, JC, Pang, H, Rushing, C, Cohn, A, Starodub, A, Arrowood, C, Haley, S, Meadows, KL, Morse, MA, Uronis, HE, Blobe, GC, Hsu, SD, Zafar, SY, and Hurwitz, HI. "Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer." Invest New Drugs 32, no. 2 (April 2014): 330-339. Full Text Link to Item
  - Cleary, JM, Lima, CMSR, Hurwitz, HI, Montero, AJ, Franklin, C, Yang, J, Graham, A, Busman, T, Mabry, M, Holen, K, Shapiro, GI, and Uronis, H. "A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors." Investigational New Drugs 32, no. 5 (2014): 937-945. Full Text
  - Dorth, JA, Pura, JA, Palta, M, Willett, CG, Uronis, HE, D'Amico, TA, and Czito, BG. "Patterns of recurrence after trimodality therapy for esophageal cancer." Cancer 120, no. 14 (January 1, 2014): 2099-2105. Full Text
  - Rangwala, F, Bendell, JC, Kozloff, MF, Arrowood, CC, Dellinger, A, Meadows, J, Tourt-Uhlig, S, Murphy, J, Meadows, KL, Starr, A, Broderick, S, Brady, JC, Cushman, SM, Morse, MA, Uronis, HE, Hsu, SD, Zafar, SY, Wallace, J, Starodub, AN, Strickler, JH, Pang, H, Nixon, AB, and Hurwitz, HI. "Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors." Investigational New Drugs 32, no. 4 (January 1, 2014): 700-709. Full Text
  - Strickler, JH, McCall, S, Nixon, AB, Brady, JC, Pang, H, Rushing, C, Cohn, A, Starodub, A, Arrowood, C, Haley, S, Meadows, KL, Morse, MA, Uronis, HE, Blobe, GC, Hsu, SD, Zafar, SY, and Hurwitz, HI. "Phase i study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer." Investigational New Drugs 32, no. 2 (January 1, 2014): 330-339. Full Text
  - Jaffe, TA, Neville, AM, Bashir, MR, Uronis, HE, and Thacker, JM. "Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?." Colorectal Dis 15, no. 11 (November 2013): e654-e658. Full Text Link to Item
  - Meadows, KL, Lee, PH, Riedel, RF, Morse, MA, Uronis, HE, Blobe, GC, George, DJ, Crawford, J, and Hurwitz, HI. "Abstract C61: Phase I Study of pazopanib in combination with the investigational hypoxia-targeted drug TH-302." Molecular Cancer Therapeutics 12, no. 11_Supplement (November 1, 2013): C61-C61. Full Text
  - Uronis, HE, Cushman, SM, Bendell, JC, Blobe, GC, Morse, MA, Nixon, AB, Dellinger, A, Starr, MD, Li, H, Meadows, K, Gockerman, J, Pang, H, and Hurwitz, HI. "A phase I study of ABT-510 plus bevacizumab in advanced solid tumors." Cancer Med 2, no. 3 (June 2013): 316-324. Full Text Open Access Copy Link to Item
  - Zhong, J, Palta, M, Willett, CG, McCall, SJ, Bulusu, A, Tyler, DS, White, RR, Uronis, HE, Pappas, TN, and Czito, BG. "The role of local excision in invasive adenocarcinoma of the ampulla of Vater." J Gastrointest Oncol 4, no. 1 (March 2013): 8-13. Full Text Link to Item
  - Pepek, JM, Chino, JP, Willett, CG, Palta, M, Blazer Iii, DG, Tyler, DS, Uronis, HE, and Czito, BG. "Preoperative chemoradiotherapy for locally advanced gastric cancer." Radiation Oncology (London, England) 8 (January 4, 2013): 6-null. Full Text
  - Uronis, HE, Bendell, JC, Altomare, I, Blobe, GC, Hsu, SD, Morse, MA, Pang, H, Zafar, SY, Conkling, P, Favaro, J, Arrowood, CC, Cushman, SM, Meadows, KL, Brady, JC, Nixon, AB, and Hurwitz, HI. "A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas." The Oncologist 18, no. 3 (January 2013): 271-272. Full Text
  - Uronis, HE, Shelby, RA, Currow, DC, Ahmedzai, SH, Bosworth, HB, Coan, A, and Abernethy, AP. "Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer." J Pain Symptom Manage 44, no. 5 (November 2012): 741-749. Full Text Link to Item
  - Strickler, JH, Starodub, AN, Jia, J, Meadows, KL, Nixon, AB, Dellinger, A, Morse, MA, Uronis, HE, Marcom, PK, Zafar, SY, Haley, ST, and Hurwitz, HI. "Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors." Cancer Chemother Pharmacol 70, no. 2 (August 2012): 251-258. Full Text Link to Item
  - Papalezova, KT, Tyler, DS, Blazer, DG, Clary, BM, Czito, BG, Hurwitz, HI, Uronis, HE, Pappas, TN, Willett, CG, and White, RR. "Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?." J Surg Oncol 106, no. 1 (July 1, 2012): 111-118. Full Text Link to Item
  - Vlahovic, G, Meadows, KL, Uronis, HE, Morse, MA, Blobe, GC, Riedel, RF, Zafar, SY, Alvarez-Secord, A, Gockerman, J, Starodub, AN, Ready, NE, Anderson, EL, Bendell, JC, and Hurwitz, HI. "A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors." Cancer Chemotherapy and Pharmacology 70, no. 1 (July 2012): 95-102. Full Text
  - Palta, M, Patel, P, Broadwater, G, Willett, C, Pepek, J, Tyler, D, Zafar, SY, Uronis, H, Hurwitz, H, White, R, and Czito, B. "Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy." Annals of Surgical Oncology 19, no. 5 (May 2012): 1535-1540. Full Text
  - Rangwala, FA, Bendell, JC, Kozloff, M, Arrowood, C, Meadows, J, Tourt-Uhlig, SE, Murphy, J, Meadows, K, Morse, M, Uronis, HE, Hsu, SD, Zafar, Y, and Hurwitz, H. "Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 30, no. 4_suppl (February 2012): 490-null.
  - Ghafoori, AP, Nelson, JW, Willett, CG, Chino, J, Tyler, DS, Hurwitz, HI, Uronis, HE, Morse, MA, Clough, RW, and Czito, BG. "Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma." Int J Radiat Oncol Biol Phys 81, no. 3 (November 1, 2011): 654-659. Full Text Link to Item
  - Uronis, H, McCrory, DC, Samsa, G, Currow, D, and Abernethy, A. "Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. (Published online)" Cochrane Database Syst Rev , no. 6 (June 15, 2011): CD006429-. (Review) Full Text Link to Item
  - Bullock, KE, Petros, WP, Younis, I, Uronis, HE, Morse, MA, Blobe, GC, Zafar, SY, Gockerman, JP, Lager, JJ, Truax, R, Meadows, KL, Howard, LA, O'Neill, MM, Broadwater, G, Hurwitz, HI, and Bendell, JC. "A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)." Cancer Chemotherapy and Pharmacology 67, no. 2 (February 2011): 465-474. Full Text
  - Palta, M, Willett, CG, Patel, P, Tyler, DS, Uronis, HE, and Czito, BG. "Carcinoma of the ampulla of Vater: Patterns of failure after resection and benefit of adjuvant radiotherapy." Journal of Clinical Oncology 29, no. 4_suppl (February 2011): 254-254. Full Text
  - Palta, M, Willett, CG, Patel, P, Tyler, DS, Uronis, HE, and Czito, BG. "Carcinoma of the ampulla of Vater: Patterns of failure after resection and benefit of adjuvant radiotherapy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 4_suppl (February 2011): 254-.
  - Pepek, JM, Chino, JP, Willett, CG, Tyler, DS, Uronis, HE, and Czito, BG. "Single-institution experience of preoperative chemoradiotherapy for locally advanced gastric cancer." Journal of Clinical Oncology 29, no. 4_suppl (February 2011): 99-99. Full Text
  - Pepek, JM, Chino, JP, Willett, CG, Tyler, DS, Uronis, HE, and Czito, BG. "Single-institution experience of preoperative chemoradiotherapy for locally advanced gastric cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 4_suppl (February 2011): 99-.
  - Starodub, A, Cohn, AL, Arrowood, C, Haley, S, Morse, M, Uronis, HE, Blobe, GC, Hsu, SD, Zafar, Y, and Hurwitz, H. "Phase I study of dasatinib in combination with capecitabine, oxaliplatin, and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 4_suppl (February 2011): 513-.
  - Altomare, I, Bendell, JC, Bullock, KE, Uronis, HE, Morse, MA, Hsu, SD, Zafar, SY, Blobe, GC, Pang, H, Honeycutt, W, Sutton, L, and Hurwitz, HI. "A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer." The Oncologist 16, no. 8 (January 2011): 1131-1137. Full Text
  - Abernethy, AP, Zafar, SY, Uronis, H, Wheeler, JL, Coan, A, Rowe, K, Shelby, RA, Fowler, R, and Herndon, JE. "Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients." J Pain Symptom Manage 40, no. 4 (October 2010): 545-558. Full Text Link to Item
  - Abernethy, AP, Uronis, HE, Wheeler, JL, and Currow, DC. "Management of dyspnea in patients with chronic obstructive pulmonary disease." Wien Med Wochenschr 159, no. 23-24 (December 2009): 583-590. (Review) Full Text Link to Item
  - Abernethy, AP, Barbour, SY, Uronis, H, Zafar, SY, Coan, A, Rowe, K, Pupa, MR, Wheeler, JL, and Herndon, JE. "Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center." Support Care Cancer 17, no. 6 (June 2009): 735-744. Full Text Link to Item
  - Uronis, HE, and Abernethy, AP. "Oxygen for relief of dyspnea: what is the evidence?." Curr Opin Support Palliat Care 2, no. 2 (June 2008): 89-94. (Review) Full Text Link to Item
  - Uronis, HE, Currow, DC, McCrory, DC, Samsa, GP, and Abernethy, AP. "Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis." British Journal of Cancer 98, no. 2 (January 8, 2008): 294-299. (Review) Full Text Open Access Copy
  - Abernethy, AP, Uronis, HE, Wheeler, JL, and Currow, DC. "Pharmacological management of breathlessness in advanced disease." Progress in Palliative Care 16, no. 1 (2008): 15-20. Full Text
  - Uronis, HE, and Bendell, JC. "Anal cancer: an overview." Oncologist 12, no. 5 (May 2007): 524-534. (Review) Full Text Link to Item
  - Uronis, HE, and Hurwitz, HI. "Is bevacizumab effective and safe in combination with chemotherapy in patients with colorectal cancer?." Nature Clinical Practice. Oncology 4, no. 4 (April 2007): 214-215. Full Text
  - Uronis, HE, McCrory, DC, Samsa, GP, Currow, DC, and Abernethy, A. "Palliative oxygen for non-hypoxaemic chronic obstructive pulmonary disease." Cochrane Database of Systematic Reviews , no. 2 (2007). Full Text
  - Uronis, HE, Currow, DC, and Abernethy, AP. "Palliative management of refractory dyspnea in COPD." Int J Chron Obstruct Pulmon Dis 1, no. 3 (2006): 289-304. (Review) Link to Item
- Conference Papers
  - Catenacci, DVT, Park, H, Uronis, HE, Kang, Y-K, Lacy, J, and Enzinger, PC. "Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+gastroesophageal adenocarcinoma (GEA) post trastuzumab (T)." : AMER SOC CLINICAL ONCOLOGY, May 20, 2018. Full Text Link to Item
  - Jia, J, Niedzwiecki, D, Uronis, HE, Morse, M, Zafar, Y, and Hsu, SD. "A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood." : AMER SOC CLINICAL ONCOLOGY, May 20, 2018. Full Text Link to Item
  - Kelly, K, Johnson, ML, Mahalingam, D, Liu, SV, Uronis, HE, and Wu, C. "A phase 2A open-label, multicenter trial of the safety and efficacy of LYC-55716, a first-in-class oral, small-molecule ROR gamma agonist to treat select solid tumors." : AMER SOC CLINICAL ONCOLOGY, May 20, 2018. Full Text Link to Item
  - Porter, LS, FIsh, L, Uronis, HE, Zafar, Y, and Steinhauser, KE. "The elephant in the room: Facilitating conversations about advanced cancer between patients and their spouses." October 9, 2016. Full Text
  - Clarke, JM, Blobe, GC, Strickler, JH, Uronis, HE, Zafar, Y, Morse, M, Dropkin, E, Howard, L, O'Neill, M, Rushing, CN, Niedzwiecki, D, Watson, H, Arrowood, C, and Hurwitz, H. "Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL)." May 20, 2016. Full Text Link to Item
  - Morris, VK, Ciombor, KK, Salem, ME, Nimeiri, HS, Iqbal, S, Singh, PP, Polite, BN, Deming, DA, Chan, E, Wade, JL, Bekaii-Saab, TS, Uronis, HE, Pasia, MG, Bland, G, Wolff, RA, Ohinata, A, Ohaji, C, Rogers, J, Sharma, P, and Eng, C. "NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA)." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL. June 3, 2016 - June 7, 2016.: AMER SOC CLINICAL ONCOLOGY, May 20, 2016. Full Text Link to Item
  - Strickler, JH, Rushing, CN, Uronis, HE, Morse, M, Blobe, GC, Zafar, Y, Hsu, SD, Arrowood, C, Ley, SH, Dropkin, E, Niedzwiecki, D, and Hurwitz, H. "Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)." May 20, 2016. Full Text Link to Item
  - Strickler, JH, Rangwala, FA, Rushing, C, Niedzwiecki, D, Altomare, I, Uronis, HE, Hsu, SD, Zafar, Y, Morse, M, Chang, DZ, Wells, JL, Blackwell, KL, Marcom, PK, Webb, AR, Dropkin, E, Arrowood, C, and Hurwitz, H. "X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC)." February 2016. Full Text
  - Zhong, J, Palta, M, Willett, CG, McCall, SJ, McSherry, F, Uronis, HE, Tyler, DS, and Czito, BG. "Patterns of Failure for Stage I Ampulla of Vater Adenocarcinoma: A Single Institutional Experience." October 2013. Full Text
  - Ryan, DP, Reddy, SG, Bahary, N, Uronis, HE, Sigal, D, Cohn, AL, Schelman, WR, Stephenson, J, Eng, C, and Borad, MJ. "TH-302 plus gemcitabine (G+T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC)." February 2013. Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Subject Headings

Selected Grants

Selected Publications

Academic Articles

Conference Papers